Panacea Biotec Limited (IN:PANACEABIO)
:PANACEABIO
Want to see IN:PANACEABIO full AI Analyst Report?
Total Valuation
Panacea Biotec Limited has a market cap or net worth of ₹32.19B. The enterprise value is ₹24.88B.
Market Cap₹32.19B
Enterprise Value₹24.88B
Share Statistics
Panacea Biotec Limited has 61,250,744 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding61,250,744
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Panacea Biotec Limited’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -4.01%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-4.01%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee3.30M
Profits Per Employee-27.74K
Employee Count1,936
Asset Turnover0.51
Inventory Turnover2.56
Valuation Ratios
The current PE Ratio of Panacea Biotec Limited is ―. Panacea Biotec Limited’s PEG ratio is 9.41.
PE Ratio―
PS Ratio2.82
PB Ratio2.16
Price to Fair Value2.16
Price to FCF-49.16
Price to Operating Cash Flow-4.52K
PEG Ratio9.41
Income Statement
In the last 12 months, Panacea Biotec Limited had revenue of 6.40B and earned -53.70M in profits. Earnings per share was -0.88.
Revenue6.40B
Gross Profit1.45B
Operating Income-377.20M
Pretax Income-73.70M
Net Income-53.70M
EBITDA-46.60M
Earnings Per Share (EPS)-0.88
Cash Flow
In the last 12 months, operating cash flow was -7.70M and capital expenditures -253.00M, giving a free cash flow of -260.70M billion.
Operating Cash Flow-7.70M
Free Cash Flow-260.70M
Free Cash Flow per Share-4.26
Dividends & Yields
Panacea Biotec Limited pays an annual dividend of ₹0.75, resulting in a dividend yield of ―
Dividend Per Share₹0.75
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change18.92%
50-Day Moving Average393.58
200-Day Moving Average386.23
Relative Strength Index (RSI)63.18
Average Volume (3m)12.44K
Important Dates
Panacea Biotec Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 30, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Panacea Biotec Limited as a current ratio of 1.47, with Debt / Equity ratio of 2.83%
Current Ratio1.47
Quick Ratio0.92
Debt to Market Cap0.01
Net Debt to EBITDA8.74
Interest Coverage Ratio-6.23
Taxes
In the past 12 months, Panacea Biotec Limited has paid -2.10M in taxes.
Income Tax-2.10M
Effective Tax Rate0.03
Enterprise Valuation
Panacea Biotec Limited EV to EBITDA ratio is -378.94, with an EV/FCF ratio of -48.05.
EV to Sales2.76
EV to EBITDA-378.94
EV to Free Cash Flow-48.05
EV to Operating Cash Flow101.84
Balance Sheet
Panacea Biotec Limited has ₹1.28B in cash and marketable securities with ₹229.00M in debt, giving a net cash position of ₹1.05B billion.
Cash & Marketable Securities₹1.28B
Total Debt₹229.00M
Net Cash₹1.05B
Net Cash Per Share₹17.22
Tangible Book Value Per Share₹127.49
Margins
Gross margin is 39.95%, with operating margin of -5.90%, and net profit margin of -0.84%.
Gross Margin39.95%
Operating Margin-5.90%
Pretax Margin-1.15%
Net Profit Margin-0.84%
EBITDA Margin-0.73%
EBIT Margin-5.90%
Analyst Forecast
The average price target for Panacea Biotec Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.43%
EPS Growth Forecast35.48%